デフォルト表紙
市場調査レポート
商品コード
939792

ウイルスろ過製品

Virus Filtration Products

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 335 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.11円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

ウイルスろ過製品
出版日: 2022年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 335 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

COVID-19による危機と迫り来る経済不況の中で、世界のウィルスろ過製品市場は予測期間中、13.6%のCAGRで成長する見込みです。キット & 試薬セグメントは14.7%以上の成長が見込まれ、予測期間末までに36億米ドルに達すると予測されています。新しいシナリオでは、米国のCAGRが12.9%に修正されています。ドイツは、今後7~8年間で1億2220万米ドルを超える市場規模の拡大が予測されています。日本のキット & 試薬セグメントは、予測期間末までに2億1820万米ドルに達する見込みです。

調査対象企業の例

  • 旭化成メディカル; Charles River Laboratories International, Inc.; General Electric Company; Lonza Group AG; Merck KgaA; MilliporeSigma; Pall Corporation; Sartorius AG; Thermo Fisher Scientific, Inc.

当レポートでは、世界のウィルスろ過製品市場について調査し、市場の概要、COVID-19が及ぼす影響、地域・国別による分析と予測、および主要企業のプロファイルなど、体系的な情報を提供しています。

第1部 イントロダクション・調査手法・調査範囲

第2部 エグゼクティブサマリー

第1章 市場概要

  • Covid-19の影響と迫り来る世界の景気後退

第2章 主要企業

第3章 市場動向・促進要因

第4章 世界市場の見通し

第3部 市場分析

  • 地域別市場分析
  • 米国
    • 市場データ
    • 米国市場:企業別状況
    • 市場分析
  • カナダ
  • 日本
  • 中国
  • 欧州
    • 市場データ
    • 市場分析
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他

第4部 競合

  • 企業プロファイル
目次
Product Code: MCP15518

Abstract:

Global Virus Filtration Products Market to Reach US$6.6 Billion by the Year 2026

Virus filtration is a non-destructive, easy, and effective method of maintaining non-enveloped and enveloped virus particles within or on the surface of polymeric membrane pores. Growth in the global market is set to be driven by extensive demand from biotechnology and biopharmaceutical industries. These industries make extensive usage of virus filtration products for protecting their products from any kind of contamination. Other growth boosting factors include favorable regulations, better funding, as well as support to various R&D projects by both private enterprises and government. Increasing investment and focus on research has boosted development of innovative technologies that facilitate manufacturing of novel filtration products capable of filtering minute structures ranging from microorganisms like viruses and bacteria to particles. Growing usage of biotherapeutics has boosted R&D as well as formulation of novel drugs extracted from different natural sources for treatment of an array of chronic disorders. The rising incidence of various diseases and chronic conditions around the world, combined with stringent regulations regarding virus-free therapeutics is likely to propel the virus-filtration industry over the medium-term. Focus on development of high-tech products, supportive government regulations, and launch of novel products is expected to benefit market growth.

Amid the COVID-19 crisis, the global market for Virus Filtration Products estimated at US$3.1 Billion in the year 2020, is projected to reach a revised size of US$6.6 Billion by 2026, growing at a CAGR of 13.1% over the analysis period. Kits & Reagents, one of the segments analyzed in the report, is projected to grow at a 14.7% CAGR to reach US$4.9 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Filtration Systems segment is readjusted to a revised 11% CAGR for the next 7-year period. This segment currently accounts for a 23.9% share of the global Virus Filtration Products market.

The U.S. Market is Estimated at $1.1 Billion in 2021, While China is Forecast to Reach $899.5 Million by 2026

The Virus Filtration Products market in the U.S. is estimated at US$1.1 Billion in the year 2021. The country currently accounts for a 31.98% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$899.5 Million in the year 2026 trailing a CAGR of 16.8% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.7% and 11.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR while Rest of European market (as defined in the study) will reach US$322.9 Million by the end of the analysis period. The virus filtration market is dominated by North America owing to growth in industrialization, patient awareness, presence of modern infrastructure, as well as high per capita expenditure on healthcare. The European market benefits from favorable policies by the government with respect to healthcare infrastructure. Growth in Asia-Pacific region is due to increased demand for high-quality therapeutics in large countries such as China and India. In developing countries like China and India, robust economic growth is supporting biotechnology and pharmaceutical units.

Filtration Systems Segment to Reach $1.4 Billion by 2026

A considerable portion of the growth for virus filtration comes from the biopharmaceutical sector. Amidst the rise in single use filtration products and stringent quality standards, the biopharmaceutical sector is expected to expand the market for membrane technology in the near future. In the global Filtration Systems segment, USA, Canada, Japan, China and Europe will drive the 10.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$570.8 Million in the year 2020 will reach a projected size of US$1.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$150.6 Million by the year 2026, while Latin America will expand at a 11.9% CAGR through the analysis period.

Select Competitors (Total 41 Featured) -

  • Asahi Kasei Medical Co., Ltd.
  • Charles River Laboratories International, Inc.
  • General Electric Company
  • Lonza Group AG
  • Merck KgaA
  • MilliporeSigma
  • Pall Corporation
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • Virus Filtration Membranes
    • A Prelude to Virus Filtration
    • Virus Filtration in Biopharmaceuticals
    • Enhanced mAb Concentration
    • Impact of Covid-19 and a Looming Global Recession
    • 2020: A Year of Disruption & Transformation
    • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
    • EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • COVID-19 Impact on Virus Filtration Market
    • Global Market Prospects and Outlook
    • Virus Filtration Market Set for a Rapid Growth
    • Segment Analysis
    • Developed Regions Dominate, Developing to Witness Fastest Growth
    • Market Challenges
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • An Expanding Biopharmaceuticals Sector Drives Growth Opportunities
    • EXHIBIT 2: Global Biopharmaceuticals Market: Revenues in US$ Billion for the Years 2019, 2021, 2023 and 2025
    • EXHIBIT 3: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
    • Pharmaceutical industry Opens Growth Avenues for Virus Filtration
    • EXHIBIT 4: Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025
    • Advanced Virus Filters in the Pharmaceutical Industry
    • Filtration Technological Advancements Drive Market Growth
    • Filtration using Adsorption
    • Filtration Advancements
    • Mask Tracking and Tracing
    • Demographic Trends & Growing Incidence of Chronic Diseases to Push the Market Ahead
    • EXHIBIT 5: Global Population Statistics for the 60+ Age Group by Geographic Region: 2019
    • EXHIBIT 6: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • EXHIBIT 7: World Diabetes and Population Statistics (2019, 2030 & 2045)
    • Expansion of Single-Use Technologies in Virus Filtration Products
    • Virus Filtration for Biopharmaceutical Production
    • The Advent of Continuous Process Methods Drives Market Growth
    • Parvovirus Filtration Registers Steady Growth
    • Virus Retentive Filters Witness Rapid Growth
    • New Air Filters to Fight Against COVID-19
    • Manufacturers Show Virus Filtration Safety Techniques
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Virus Filtration Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Virus Filtration Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Virus Filtration Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
    • TABLE 4: World Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 7: World Current & Future Analysis for Filtration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Filtration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Filtration Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 10: World Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 13: World Current & Future Analysis for Biologicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Biologicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Biologicals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 16: World Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 19: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 22: World Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 25: World Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 28: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 31: USA Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 34: USA Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: USA Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: USA 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 37: USA Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: USA Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: USA 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • CANADA
    • TABLE 40: Canada Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Canada Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Canada 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 43: Canada Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Canada Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Canada 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 46: Canada Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Canada Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Canada 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • JAPAN
    • TABLE 49: Japan Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Japan Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Japan 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 52: Japan Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Japan Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Japan 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 55: Japan Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Japan Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Japan 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • CHINA
    • TABLE 58: China Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: China Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: China 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 61: China Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: China Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: China 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 64: China Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: China Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: China 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • EUROPE
    • TABLE 67: Europe Current & Future Analysis for Virus Filtration Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 68: Europe Historic Review for Virus Filtration Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Europe 15-Year Perspective for Virus Filtration Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
    • TABLE 70: Europe Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Europe Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Europe 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 73: Europe Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Europe Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Europe 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 76: Europe Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Europe Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Europe 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • FRANCE
    • TABLE 79: France Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: France Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: France 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 82: France Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: France Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: France 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 85: France Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: France Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: France 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • GERMANY
    • TABLE 88: Germany Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Germany Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Germany 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 91: Germany Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Germany Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Germany 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 94: Germany Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Germany Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Germany 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • ITALY
    • TABLE 97: Italy Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Italy Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Italy 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 100: Italy Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Italy Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Italy 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 103: Italy Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Italy Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Italy 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • UNITED KINGDOM
    • TABLE 106: UK Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: UK Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: UK 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 109: UK Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: UK Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: UK 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 112: UK Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: UK Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: UK 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • SPAIN
    • TABLE 115: Spain Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Spain Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: Spain 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 118: Spain Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Spain Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Spain 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 121: Spain Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Spain Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: Spain 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • RUSSIA
    • TABLE 124: Russia Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Russia Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: Russia 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 127: Russia Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Russia Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Russia 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 130: Russia Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Russia Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Russia 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF EUROPE
    • TABLE 133: Rest of Europe Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Europe Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Rest of Europe 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 136: Rest of Europe Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Rest of Europe Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Rest of Europe 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 139: Rest of Europe Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Rest of Europe Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Rest of Europe 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • ASIA-PACIFIC
    • TABLE 142: Asia-Pacific Current & Future Analysis for Virus Filtration Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 143: Asia-Pacific Historic Review for Virus Filtration Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Asia-Pacific 15-Year Perspective for Virus Filtration Products by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
    • TABLE 145: Asia-Pacific Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Asia-Pacific Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Asia-Pacific 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 148: Asia-Pacific Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Asia-Pacific Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Asia-Pacific 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 151: Asia-Pacific Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Asia-Pacific Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Asia-Pacific 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • AUSTRALIA
    • TABLE 154: Australia Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Australia Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Australia 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 157: Australia Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Australia Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Australia 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 160: Australia Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Australia Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: Australia 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • INDIA
    • TABLE 163: India Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: India Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: India 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 166: India Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: India Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: India 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 169: India Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: India Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: India 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • SOUTH KOREA
    • TABLE 172: South Korea Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: South Korea Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: South Korea 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 175: South Korea Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: South Korea Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: South Korea 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 178: South Korea Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: South Korea Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: South Korea 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 181: Rest of Asia-Pacific Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Rest of Asia-Pacific Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: Rest of Asia-Pacific 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 184: Rest of Asia-Pacific Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Rest of Asia-Pacific Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Rest of Asia-Pacific 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 187: Rest of Asia-Pacific Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Rest of Asia-Pacific Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Rest of Asia-Pacific 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • LATIN AMERICA
    • TABLE 190: Latin America Current & Future Analysis for Virus Filtration Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 191: Latin America Historic Review for Virus Filtration Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Latin America 15-Year Perspective for Virus Filtration Products by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
    • TABLE 193: Latin America Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Latin America Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: Latin America 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 196: Latin America Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Latin America Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: Latin America 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 199: Latin America Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Latin America Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: Latin America 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • ARGENTINA
    • TABLE 202: Argentina Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Argentina Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: Argentina 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 205: Argentina Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Argentina Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Argentina 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 208: Argentina Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Argentina Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Argentina 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • BRAZIL
    • TABLE 211: Brazil Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Brazil Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 213: Brazil 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 214: Brazil Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 215: Brazil Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 216: Brazil 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 217: Brazil Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 218: Brazil Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 219: Brazil 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • MEXICO
    • TABLE 220: Mexico Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 221: Mexico Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 222: Mexico 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 223: Mexico Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 224: Mexico Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 225: Mexico 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 226: Mexico Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 227: Mexico Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 228: Mexico 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF LATIN AMERICA
    • TABLE 229: Rest of Latin America Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 230: Rest of Latin America Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 231: Rest of Latin America 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 232: Rest of Latin America Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 233: Rest of Latin America Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 234: Rest of Latin America 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 235: Rest of Latin America Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 236: Rest of Latin America Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 237: Rest of Latin America 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • MIDDLE EAST
    • TABLE 238: Middle East Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 239: Middle East Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 240: Middle East 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 241: Middle East Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 242: Middle East Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 243: Middle East 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 244: Middle East Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 245: Middle East Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 246: Middle East 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • AFRICA
    • TABLE 247: Africa Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 248: Africa Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 249: Africa 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 250: Africa Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 251: Africa Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 252: Africa 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 253: Africa Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 254: Africa Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 255: Africa 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027

IV. COMPETITION

  • Total Companies Profiled: 41